Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease
Objective: Non-alcoholic fatty liver disease (NAFLD) as the most common chronic liver disease is associated with metabolic disorders including dysregulated lipid and glucose metabolism. There is no approved drug treatment for NAFLD; thus, new therapies are needed. We studied the antidyslipidemic eff...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mashhad University of Medical Sciences
2025-06-01
|
| Series: | Avicenna Journal of Phytomedicine |
| Subjects: | |
| Online Access: | https://ajp.mums.ac.ir/article_25220_f185e7a30383834d31f91c77bc5b31c9.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849312927830507520 |
|---|---|
| author | Zahra Eslami Hamidreza Joshaghani Abdorreza Eghbal Moghanlou Alireza Norouzi Seyed Javad Mirghani |
| author_facet | Zahra Eslami Hamidreza Joshaghani Abdorreza Eghbal Moghanlou Alireza Norouzi Seyed Javad Mirghani |
| author_sort | Zahra Eslami |
| collection | DOAJ |
| description | Objective: Non-alcoholic fatty liver disease (NAFLD) as the most common chronic liver disease is associated with metabolic disorders including dysregulated lipid and glucose metabolism. There is no approved drug treatment for NAFLD; thus, new therapies are needed. We studied the antidyslipidemic effects of atorvastatin and/or possibly hepatoprotective effects of flaxseed/ flaxseed oil in a rat model of NAFLD.Materials and Methods: Fifty-six male Wistar rats were divided randomly into seven groups: 1) control, 2) high-fructose diet (HFD), 3) HFD +atorvastatin (20 mg/kg), 4) HFD+ flaxseed (40 g/kg), 5) HFD+ flaxseed oil (40 mg/kg), 6) HFD+flaxseed (40 g/kg) + atorvastatin (20 mg/kg) and 7) HFD+flaxseed oil (40 g/kg) +atorvastatin (20 mg/kg). The interventions were done for 23 weeks, after which anthropometric indices, lipid profile, liver enzymes, fasting blood glucose, and kidney indices were analyzed. Scoring of hematoxylin-eosin-stained liver sections was used to assess the severity of NAFLD.Results: All the treatments reduced mesenteric fat mass, and the amount of fat around the liver, except in HFD+ flaxseed +atorvastatin group. The interventions improved NAFLD activity score, which considers steatosis, lobular inflammation, and hepatocyte ballooning. However, atorvastatin was most efficient in reducing inflammation and hepatocyte ballooning. While atorvastatin reduced only Gamma-glutamyltransferase (GGT) levels, flaxseed or flaxseed oil mono- and combination therapies reduced serum levels of all liver enzymes. The interventions improved the serum lipid profile and all, except atorvastatin decreased fasting blood glucose.Conclusion: Flaxseed therapies improved NAFLD-associated liver injuries and dyslipidemia, while atorvastatin mostly reduced hepatocyte ballooning and lobular inflammation. |
| format | Article |
| id | doaj-art-d14f0736c2564088a47d64ca742d9b61 |
| institution | Kabale University |
| issn | 2228-7930 2228-7949 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Mashhad University of Medical Sciences |
| record_format | Article |
| series | Avicenna Journal of Phytomedicine |
| spelling | doaj-art-d14f0736c2564088a47d64ca742d9b612025-08-20T03:52:56ZengMashhad University of Medical SciencesAvicenna Journal of Phytomedicine2228-79302228-79492025-06-011531102111210.22038/ajp.2024.2522025220Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver diseaseZahra Eslami0Hamidreza Joshaghani1Abdorreza Eghbal Moghanlou2Alireza Norouzi3Seyed Javad Mirghani4Department of Clinical Biochemistry, Hamadan university of medical science, Hamadan, Iran.Laboratory sciences research center, Golestan University of Medical Sciences, Gorgan, IranIstanbul esenyurt University, Physical Education and Sports High School, Coaching Education Department, Istanbul, TurkeyGolestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, IranShahid Mirghani Research Institute, Gorgan, Golestan, IranObjective: Non-alcoholic fatty liver disease (NAFLD) as the most common chronic liver disease is associated with metabolic disorders including dysregulated lipid and glucose metabolism. There is no approved drug treatment for NAFLD; thus, new therapies are needed. We studied the antidyslipidemic effects of atorvastatin and/or possibly hepatoprotective effects of flaxseed/ flaxseed oil in a rat model of NAFLD.Materials and Methods: Fifty-six male Wistar rats were divided randomly into seven groups: 1) control, 2) high-fructose diet (HFD), 3) HFD +atorvastatin (20 mg/kg), 4) HFD+ flaxseed (40 g/kg), 5) HFD+ flaxseed oil (40 mg/kg), 6) HFD+flaxseed (40 g/kg) + atorvastatin (20 mg/kg) and 7) HFD+flaxseed oil (40 g/kg) +atorvastatin (20 mg/kg). The interventions were done for 23 weeks, after which anthropometric indices, lipid profile, liver enzymes, fasting blood glucose, and kidney indices were analyzed. Scoring of hematoxylin-eosin-stained liver sections was used to assess the severity of NAFLD.Results: All the treatments reduced mesenteric fat mass, and the amount of fat around the liver, except in HFD+ flaxseed +atorvastatin group. The interventions improved NAFLD activity score, which considers steatosis, lobular inflammation, and hepatocyte ballooning. However, atorvastatin was most efficient in reducing inflammation and hepatocyte ballooning. While atorvastatin reduced only Gamma-glutamyltransferase (GGT) levels, flaxseed or flaxseed oil mono- and combination therapies reduced serum levels of all liver enzymes. The interventions improved the serum lipid profile and all, except atorvastatin decreased fasting blood glucose.Conclusion: Flaxseed therapies improved NAFLD-associated liver injuries and dyslipidemia, while atorvastatin mostly reduced hepatocyte ballooning and lobular inflammation.https://ajp.mums.ac.ir/article_25220_f185e7a30383834d31f91c77bc5b31c9.pdfstatinflaxliverlinseed oilsteatosis |
| spellingShingle | Zahra Eslami Hamidreza Joshaghani Abdorreza Eghbal Moghanlou Alireza Norouzi Seyed Javad Mirghani Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease Avicenna Journal of Phytomedicine statin flax liver linseed oil steatosis |
| title | Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease |
| title_full | Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease |
| title_fullStr | Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease |
| title_full_unstemmed | Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease |
| title_short | Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease |
| title_sort | atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet induced rat model of non alcoholic fatty liver disease |
| topic | statin flax liver linseed oil steatosis |
| url | https://ajp.mums.ac.ir/article_25220_f185e7a30383834d31f91c77bc5b31c9.pdf |
| work_keys_str_mv | AT zahraeslami atorvastatinandflaxseeddietarytreatmentsimprovedyslipidemiaandliverinjuriesinadietinducedratmodelofnonalcoholicfattyliverdisease AT hamidrezajoshaghani atorvastatinandflaxseeddietarytreatmentsimprovedyslipidemiaandliverinjuriesinadietinducedratmodelofnonalcoholicfattyliverdisease AT abdorrezaeghbalmoghanlou atorvastatinandflaxseeddietarytreatmentsimprovedyslipidemiaandliverinjuriesinadietinducedratmodelofnonalcoholicfattyliverdisease AT alirezanorouzi atorvastatinandflaxseeddietarytreatmentsimprovedyslipidemiaandliverinjuriesinadietinducedratmodelofnonalcoholicfattyliverdisease AT seyedjavadmirghani atorvastatinandflaxseeddietarytreatmentsimprovedyslipidemiaandliverinjuriesinadietinducedratmodelofnonalcoholicfattyliverdisease |